BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 24145052)

  • 1. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.
    Kirbas A; Kirbas S; Cure MC; Tufekci A
    J Clin Neurosci; 2014 Mar; 21(3):451-5. PubMed ID: 24145052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
    Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A
    J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.
    Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A
    Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S; Aslan M; Horoz M; Gur M; Erel O
    Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum paraoxonase, arylesterase activities and oxidative status in patients with insomnia.
    Liang B; Li YH; Kong H
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2517-22. PubMed ID: 24089233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
    Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
    Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of single hemodialysis session on serum paraoxonase-1, arylesterase activity, total oxıdant status and total antioxidant status.
    Yildiz G; Aydin H; Mağden K; Yilmaz A; Hür E; Candan F
    Minerva Med; 2014 Feb; 105(1):79-87. PubMed ID: 24572453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS).
    Baysal E; Taysi S; Aksoy N; Uyar M; Celenk F; Karatas ZA; Tarakcioglu M; Bilinç H; Mumbuç S; Kanlikama M
    Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):770-4. PubMed ID: 22913209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the serum paraoxonase activity and oxidant/antioxidant status in patients with recurrent aphthous stomatitis.
    Bilgili SG; Ozkol H; Takci Z; Ozkol HU; Karadag AS; Aslan M
    Int J Dermatol; 2013 Oct; 52(10):1259-64. PubMed ID: 23834345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of thiols, paraoxonase 1, arylesterase and oxidative balance in colorectal cancer in human.
    Bulbuller N; Eren E; Ellidag HY; Oner OZ; Sezer C; Aydin O; Yılmaz N
    Neoplasma; 2013; 60(4):419-24. PubMed ID: 23581414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Serum Paraoxonase, Arylesterase, Prolidase Activities and Oxidative Stress in Patients with Alopecia Areata.
    Dizen-Namdar N; Emel Kocak F; Kidir M; Sarici G; Tak H; Altuntas I
    Skin Pharmacol Physiol; 2019; 32(2):59-64. PubMed ID: 30544126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major.
    Cakmak A; Soker M; Koc A; Erel O
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):583-7. PubMed ID: 19636263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase and arylesterase activities in fibromyalgia.
    Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S
    Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase and arylesterase activities in coronary artery disease.
    Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
    Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation of the total antioxidant status (TAS), total oxidant status (TOS) and paraoxonase activity (PON1) with smoking.
    Aslan R; Kutlu R; Civi S; Tasyurek E
    Clin Biochem; 2014 Apr; 47(6):393-7. PubMed ID: 24440837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of levothyroxine sodium treatment on oxidative stress in Hashimoto's thyroiditis.
    Ates I; Altay M; Yilmaz FM; Topcuoglu C; Yilmaz N; Berker D; Guler S
    Eur J Endocrinol; 2016 Jun; 174(6):727-34. PubMed ID: 26951600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
    Soyoral YU; Aslan M; Emre H; Begenik H; Erdur FM; Turkel A; Selek S; Erkoc R
    Atherosclerosis; 2011 Sep; 218(1):243-6. PubMed ID: 21723555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urotensin-II level and its association with oxidative stress in early diabetic nephropathy.
    Tabur S; Korkmaz H; Eren MA; Oğuz E; Sabuncu T; Aksoy N
    J Diabetes Complications; 2015; 29(1):115-9. PubMed ID: 25179234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism.
    Cebeci E; Oner FA; Usta M; Yurdakul S; Erguney M
    Acta Biomed; 2011 Dec; 82(3):214-22. PubMed ID: 22783718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
    Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
    Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.